Birdwatch Archive

Birdwatch Note Rating

2024-09-30 09:33:43 UTC - HELPFUL

Rated by Participant: 7CCD692718B3B22D7CE487CB93C72946A0ABA042886B6CE48CA21CCC91B57E64
Participant Details

Original Note:

本治験は A群:ワクチン→3か月程観察①A→プラセボ→4か月程観察②A B群:プラセボ→3か月間観察①B→ワクチン→4か月程観察②B の4期間で ①A死亡5(コロナ死1 ①B死亡16(コロナ死9 ②A死亡9 ②B死亡4 で全死亡は接種との因果関係が否定され(各群八千人程 下記pdf29p https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=29 即ち有効性評価期間①でプラセボは3倍以上死亡しているという話です。 そしてプラセボ群の方が死者が多いという話は、勿論、最初にプラセボをうった群、B群が、レプリコンワクチンを打つ前の話です。

All Note Details

Original Tweet

All Information

  • noteId - 1840685314970628558
  • participantId -
  • raterParticipantId - 7CCD692718B3B22D7CE487CB93C72946A0ABA042886B6CE48CA21CCC91B57E64
  • createdAtMillis - 1727688823663
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 18406853149706285587CCD692718B3B22D7CE487CB93C72946A0ABA042886B6CE48CA21CCC91B57E64